| [1] |
Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.
Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer
[J]. Journal of International Oncology, 2024, 51(6): 321-325.
|
| [2] |
He Jiahui, Hu Qinyong.
Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data
[J]. Journal of International Oncology, 2024, 51(1): 29-36.
|
| [3] |
Li Bin, Zhang Guifang, Zhou Linjing, Yang Xiaodong, He Qiuli, Jia Sisi, Huang Puchao, Liang Jiaxin.
Relationships between PIK3CA gene status and clinical features and prognosis in triple-negative breast cancer
[J]. Journal of International Oncology, 2023, 50(5): 263-267.
|
| [4] |
Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng.
Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection
[J]. Journal of International Oncology, 2023, 50(12): 711-716.
|
| [5] |
Chen Yu, Xu Hua, Liu Hai, Chen Shixin.
Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging
[J]. Journal of International Oncology, 2023, 50(11): 655-660.
|
| [6] |
Zhang Jingxian, Su Jianfei, Wei Xueqin, Yi Dan, Li Xiaojiang.
Treatment status of non-small cell lung cancer with METexon14 skipping mutation
[J]. Journal of International Oncology, 2023, 50(1): 37-41.
|
| [7] |
Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun.
Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model
[J]. Journal of International Oncology, 2022, 49(9): 532-536.
|
| [8] |
Chen Huangjing, Zhu Pengfei, Zhang Qing, Chen Guifang, Yang Chunlin, He Ying.
Comparative study on the clinical value of contrast-enhanced ultrasound- and CT-guided percutaneous puncture biopsy in peripheral lung masses
[J]. Journal of International Oncology, 2022, 49(8): 459-463.
|
| [9] |
Cai Gangxiang, Li Jing, Xu Bin.
Advances in neoadjuvant immunotherapy for lung cancer
[J]. Journal of International Oncology, 2022, 49(6): 366-370.
|
| [10] |
Zhang Jingxian, Yi Dan, Li Xiaojiang.
Application of antibody-drug conjugates in the treatment of non-small cell lung cancer
[J]. Journal of International Oncology, 2022, 49(5): 296-301.
|
| [11] |
Gao Min, Feng Jing, Wang Li, Zhong Hai, Wen Yuting, Wan Bing, Zhang Xiuwei.
Application of microbiota in the early diagnosis and adjunctive treatment of lung cancer
[J]. Journal of International Oncology, 2022, 49(4): 247-251.
|
| [12] |
Gao Shile, Lu Donghui, Liu Meiqin, Xu Xingjun, Ma Huan, Zhang Yu.
Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer
[J]. Journal of International Oncology, 2022, 49(3): 140-145.
|
| [13] |
Xie Hongxia, Zuo Jinhui, Liao Dongying, Deng Renfen, Yao Yang, Jia Yingjie, Li Xiaojiang, Kong Fanming.
Application of PD-L1 inhibitors in the treatment of non-small cell lung cancer
[J]. Journal of International Oncology, 2022, 49(2): 111-115.
|
| [14] |
Huang Huayu, Song Qibin, Gong Hongyun, Song Jia.
Analysis on the incidence and risk factors of pneumonia in patients with lung cancer receiving thoracic radiotherapy and immunotherapy
[J]. Journal of International Oncology, 2022, 49(12): 718-723.
|
| [15] |
Zhang Hongjiao, Jiang Jie, Huang Wei.
Research progress of functional imaging-assisted radiotherapy target delineation of lung cancer with atelectasis
[J]. Journal of International Oncology, 2022, 49(1): 51-55.
|
